StockClub
ESLAEstrella Immunopharma, Inc.$ --
Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc.

ESLA

$ -

-

You can review balance sheet highlights, composition, equity ratio trends, and annual balance sheet line items.

account_balanceBalance Sheet (BS) Summary

2025/12 Filed: 2026-03-18

Total Assets

account_balance
3.2M USD
No comparison

Shareholders' Equity

savings
-10.4M USD
No comparison

Equity Ratio

pie_chart
-326.3%
No comparison

Book Value Per Share

paid
-0.25USD
No comparison

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %
21.510.50
2021
2022
2024
2025

Balance Sheet Details

Item
2021
2022
2024
2025
Cash
Cash and Equivalents
Short-term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
1.38M
1.38M
0
0
0
292,673
1.68M
Goodwill
Intangible Assets
Property, Plant and Equipment
Property, Plant and Equipment Net
Long-term Investments
Other Assets
Other Non-current Assets
Net Tangible Assets
Non-current Assets Total
Total Assets
0
0
0
0
0
0
1.50M
3.18M
1.50M
3.18M
Accounts Payable
Short-term Debt
Short/Current Long-term Debt
Current Deferred Revenue
Other Current Liabilities
Total Current Liabilities
554,781
0
0
0
12.93M
13.54M
Long-term Debt
Long-term Debt Total
Capital Lease Obligations
Other Non-current Liabilities
Net Debt
Non-current Liabilities Total
Total Liabilities
0
0
0
0
-1.38M
0
13.54M
Common Stock
Common Stock Shares Outstanding
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Other Stockholder Equity
Treasury Stock
Total Stockholder Equity
3,849
36.82M
27.22M
-36.99M
0
0
-598,379
-10.37M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.